Streamlined, automated protocols for the production of milligram quantities of untagged recombinant human cyclophilin-A (hCypA) and untagged human proliferating cell nuclear antigen (hPCNA) using ÄKTAxpress™

Protein Expression and Purification

Volumn 71, Issue 1, 2010, Pages 54-61

  Ludwig, Cornelia ^a   Wear, Martin A ^a   Walkinshaw, Malcolm D ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

Author keywords

KTAXpress ; Automated protein purification; Cyclophilin A; Liquid chromatography; PCNA

Indexed keywords

CYCLINE; CYCLOPHILIN A; RECOMBINANT PROTEIN;

ARTICLE; AUTOMATION; BIOSYNTHESIS; HUMAN; ISOLATION AND PURIFICATION; LIQUID CHROMATOGRAPHY; METHODOLOGY;

AUTOMATION; CHROMATOGRAPHY, LIQUID; CYCLOPHILIN A; HUMANS; PROLIFERATING CELL NUCLEAR ANTIGEN; RECOMBINANT PROTEINS;

ESCHERICHIA COLI;

EID: 77049095131     PISSN: 10465928     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pep.2009.12.001     Document Type: Article

References (48)

1. Chambers S.P., Fulghum J.R., Austen D.A., Lu F., and Swalley S.E. E. Coli and insect cell expression, automated purification and quantitative analysis. Methods Mol. Biol. 498 (2009) 143-156
2. Hiraki M., Kato R., Nagai M., Satoh T., Hirano S., Ihara K., Kudo N., Nagae M., Kobayashi M., Inoue M., Uejima T., Oda S., Chavas L.M., Akutsu M., Yamada Y., Kawasaki M., Matsugaki N., Igarashi N., Suzuki M., and Wakatsuki S. Development of an automated large-scale protein-crystallization and monitoring system for high-throughput protein-structure analyses. Acta Crystallogr. D Biol. Crystallogr. 62 (2006) 1058-1065
3. Alzari P.M., Berglund H., Berrow N.S., Blagova E., Busso D., Cambillau C., Campanacci V., Christodoulou E., Eiler S., Fogg M.J., Folkers G., Geerlof A., Hart D., Haouz A., Herman M.D., Macieira S., Nordlund P., Perrakis A., Quevillon-Cheruel S., Tarandeau F., van Tilbeurgh H., Unger T., Luna-Vargas M.P., Velarde M., Willmanns M., and Owens R.J. Implementation of semi-automated cloning and prokaryotic expression screening: the impact of SPINE. Acta Crystallogr. D Biol. Crystallogr. 62 (2006) 1103-1113
4. Au K., Berrow N.S., Blagova E., Boucher I.W., Boyle M.P., Brannigan J.A., Carter L.G., Dierks T., Folkers G., Grenha R., Harlos K., Kaptein R., Kalliomaa A.K., Levdikov V.M., Meier C., Milioti N., Moroz O., Muller A., Owens R.J., Rzechorzek N., Sainsbury S., Stuart D.I., Walter T.S., Waterman D.G., Wilkinson A.J., Wilson K.S., Zaccai N., Esnouf R.M., and Fogg M.J. Application of high-throughput technologies to a structural proteomics-type analysis of Bacillus anthracis. Acta Crystallogr. D Biol. Crystallogr. 62 (2006) 1267-1275
5. Berrow N.S., Bussow K., Coutard B., Diprose J., Ekberg M., Folkers G.E., Levy N., Lieu V., Owens R.J., Peleg Y., Pinaglia C., Quevillon-Cheruel S., Salim L., Scheich C., Vincentelli R., and Busso D. Recombinant protein expression and solubility screening in Escherichia coli: a comparative study. Acta Crystallogr. D Biol. Crystallogr. 62 (2006) 1218-1226
6. Bhikhabhai R., Sjöberg A., Hedkvist L., Galin M., Liljedahl P., Frigård T., Pettersson N., Nilsson M., Sigrell-Simon J.A., and Markeland-Johansson C. Production of milligram quantities of affinity tagged-proteins using automated multistep chromatographic purification. J. Chromatogr. A 1080 (2005) 83-92
7. Stromberg P., Rotticci-Mulder J., Bjornestedt R., and Schmidt S.R. Preparative parallel protein purification (P4). J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 818 (2005) 11-18
8. Riek U., Ramirez S., Wallimann T., and Schlattner U. A versatile multidimensional protein purification system with full Internet remote control based on a standard HPLC system. Biotechniques 46 (2009) ix-xii
9. Sakamoto S., Kabe Y., Hatakeyama M., Yamaguchi Y., and Handa H. Development and application of high-performance affinity beads: toward chemical biology and drug discovery. Chem. Rec. 9 (2009) 66-85
10. Zhou J.X., Tressel T., Yang X., and Seewoester T. Implementation of advanced technologies in commercial monoclonal antibody production. Biotechnol. J. 3 (2008) 1185-1200
11. Waugh D.S. Making the most of affinity tags. Trends Biotechnol. 23 (2005) 316-320
12. Liu H., and Naismith J.H. A simple and efficient expression and purification system using two newly constructed vectors. Protein Expr. Purif. 63 (2009) 102-111
13. Wu J., and Filutowicz M. Hexahistidine (His6)-tag dependent protein dimerization: a cautionary tale. Acta Biochim. Pol. 46 (1999) 591-599
14. Wear M.A., Patterson A., and Walkinshaw M.D. A kinetically trapped intermediate of FK506 binding protein forms in vitro: chaperone machinery dominates protein folding in vivo. Protein Expr. Purif. 51 (2007) 80-95
15. Galat A. Peptidyl prolyl cis/trans isomerases (immunophilins): biological diversity - targets - functions. Curr. Top. Med. Chem. 3 (2003) 1315-1347
16. Page A.P., MacNiven K., and Hengartner M.O. Cloning and biochemical characterization of the cyclophilin homologues from the free-living nematode Caenorhabditis elegans. Biochem. J. 317 Pt. 1 (1996) 179-185
17. Fanghanel J., and Fischer G. Insights into the catalytic mechanism of peptidyl prolyl cis/trans isomerases. Front. Biosci. 9 (2004) 3453-3478
18. Handschumacher R.E., Harding M.W., Rice J., Drugge R.J., and Speicher D.W. Cyclophilin: a specific cytosolic binding protein for cyclosporin A. Science 226 (1984) 544-547
19. Liu J., Farmer Jr. J.D., Lane W.S., Friedman J., Weissman I., and Schreiber S.L. Calcineurin is a common target of cyclophilin-cyclosporin A and FKBP-FK506 complexes. Cell 66 (1991) 807-815
20. Rovira P., Mascarell L., and Truffa-Bachi P. The impact of immunosuppressive drugs on the analysis of T cell activation. Curr. Med. Chem. 7 (2000) 673-692
21. Cantin R., Methot S., and Tremblay M.J. Plunder and stowaways: incorporation of cellular proteins by enveloped viruses. J. Virol. 79 (2005) 6577-6587
22. Guichou J.F., Viaud J., Mettling C., Subra G., Lin Y.L., and Chavanieu A. Structure-based design, synthesis, and biological evaluation of novel inhibitors of human cyclophilin A. J. Med. Chem. 49 (2006) 900-910
23. Watashi K., Ishii N., Hijikata M., Inoue D., Murata T., Miyanari Y., and Shimotohno K. Cyclophilin B is a functional regulator of hepatitis C virus RNA polymerase. Mol. Cell 19 (2005) 111-122
24. Watashi K., and Shimotohno K. Current approaches for developing new anti-HCV agents and analyses of HCV replication using anti-HCV agents. Uirusu 55 (2005) 105-110
25. Bobardt M.D., Cheng G., de Witte L., Selvarajah S., Chatterji U., Sanders-Beer B.E., Geijtenbeek T.B., Chisari F.V., and Gallay P.A. Hepatitis C virus NS5A anchor peptide disrupts human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 105 (2008) 5525-5530
26. Flisiak R., Horban A., Gallay P., Bobardt M., Selvarajah S., Wiercinska-Drapalo A., Siwak E., Cielniak I., Higersberger J., Kierkus J., Aeschlimann C., Grosgurin P., Nicolas-Metral V., Dumont J.M., Porchet H., Crabbe R., and Scalfaro P. The cyclophilin inhibitor Debio-025 shows potent anti-hepatitis C effect in patients coinfected with hepatitis C and human immunodeficiency virus. Hepatology 47 (2008) 817-826
27. Chatterji U., Bobardt M., Selvarajah S., Yang F., Tang H., Sakamoto N., Vuagniaux G., Parkinson T., and Gallay P. The isomerase active site of cyclophilin a is critical for HCV replication. J. Biol. Chem. 284 25 (2009) 16998-17005
28. Bell A., Wernli B., and Franklin R.M. Roles of peptidyl-prolyl cis-trans isomerase and calcineurin in the mechanisms of antimalarial action of cyclosporin A, FK506, and rapamycin. Biochem. Pharmacol. 48 (1994) 495-503
29. Gavigan C.S., Kiely S.P., Hirtzlin J., and Bell A. Cyclosporin-binding proteins of Plasmodium falciparum. Int. J. Parasitol. 33 (2003) 987-996
30. Crompton M., Virji S., and Ward J.M. Cyclophilin-D binds strongly to complexes of the voltage-dependent anion channel and the adenine nucleotide translocase to form the permeability transition pore. Eur. J. Biochem. 258 (1998) 729-735
31. Waldmeier P.C., Zimmermann K., Qian T., Tintelnot-Blomley M., and Lemasters J.J. Cyclophilin D as a drug target. Curr. Med. Chem. 10 (2003) 1485-1506
32. Baines C.P., Kaiser R.A., Purcell N.H., Blair N.S., Osinska H., Hambleton M.A., Brunskill E.W., Sayen M.R., Gottlieb R.A., Dorn G.W., Robbins J., and Molkentin J.D. Loss of cyclophilin D reveals a critical role for mitochondrial permeability transition in cell death. Nature 434 (2005) 658-662
33. Page A.P., Kumar S., and Carlow C.K. Parasite cyclophilins and antiparasite activity of cyclosporin A. Parasitol. Today 11 (1995) 385-388
34. Yang Y., Moir E., Kontopidis G., Taylor P., Wear M.A., Malone K., Page P.A., Turner N.J., and Walkinshaw M.D. Structure-based discovery of a family of synthetic cyclophilin inhibitors showing a cyclosporin-A phenotype in C. elegans. Biochem. Biophys. Res. Commun. 363 4 (2007) 1013-1019
35. Moldovan G.L., Pfander B., and Jentsch S. PCNA, the maestro of the replication fork. Cell 129 (2007) 665-679
36. Warbrick E. A functional analysis of PCNA-binding peptides derived from protein sequence, interaction screening and rational design. Oncogene 25 (2006) 2850-2859
37. Kelman Z., and Hurwitz J. Protein-PCNA interactions: a DNA-scanning mechanism?. Trends Biochem. Sci. 23 (1998) 236-238
38. Kelman Z., Hurwitz J., and O'Donnell M. Processivity of DNA polymerases: two mechanisms, one goal. Structure 6 (1998) 121-125
39. Warbrick E., Lane D.P., Glover D.M., and Cox L.S. A small peptide inhibitor of DNA replication defines the site of interaction between the cyclin-dependent kinase inhibitor p21WAF1 and proliferating cell nuclear antigen. Curr. Biol. 5 (1995) 275-282
40. Hall P.A., Kearsey J.M., Coates P.J., Norman D.G., Warbrick E., and Cox L.S. Characterisation of the interaction between PCNA and Gadd45. Oncogene 10 (1995) 2427-2433
41. Kontopidis G., Wu S.Y., Zheleva D.I., Taylor P., McInnes C., Lane D.P., Fischer P.M., and Walkinshaw M.D. Structural and biochemical studies of human proliferating cell nuclear antigen complexes provide a rationale for cyclin association and inhibitor design. Proc. Natl. Acad. Sci. USA 102 (2005) 1871-1876
42. Wear M.A., Patterson A., Malone K., Dunsmore C., Turner N.J., and Walkinshaw M.D. A surface plasmon resonance-based assay for small molecule inhibitors of human cyclophilin A. Anal. Biochem. 345 (2005) 214-226
43. Fien K., and Stillman B. Identification of replication factor C from Saccharomyces cerevisiae: a component of the leading-strand DNA replication complex. Mol. Cell. Biol. 12 (1992) 155-163
44. Kofron J.L., Kuzmic P., Kishore V., Colon-Bonilla E., and Rich D.H. Determination of kinetic constants for peptidyl prolyl cis-trans isomerases by an improved spectrophotometric assay. Biochemistry 30 (1991) 6127-6134
45. Wear M.A., Kan D., Rabu A., and Walkinshaw M.D. Experimental determination of van der waals energies in a biological system. Angew. Chem. Int. Ed. Engl. 46 (2007) 6453-6456
46. Fischer G., Bang H., Berger E., and Schellenberger A. Conformational specificity of chymotrypsin toward proline-containing substrates. Biochim. Biophys. Acta 791 (1984) 87-97
47. Laemmli U.K. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227 (1970) 680-685
48. Wear M.A., and Walkinshaw M.D. Thermodynamics of the cyclophilin-A/cyclosporin-A interaction: a direct comparison of parameters determined by surface plasmon resonance using Biacore T100 and isothermal titration calorimetry. Anal. Biochem. 359 (2006) 285-287